is medical sales worth it 2026

Is Medical Device Sales Still Worth Pursuing in 2026?

Quick answer: Yes, medical device sales is still worth pursuing in 2026. The demand fundamentals, including an aging population, rising surgical volumes, and expanding robotic and minimally invasive procedures, are all pointing up. Compensation still lands well above what most careers offer without a graduate degree. What has changed is the preparation bar: you need more clinical knowledge and better interview skills than candidates five years ago.

Yes, it is still worth pursuing, and in a lot of ways the runway is longer than it was five years ago. The demand fundamentals (an aging population, rising surgical volumes, and expanding robotic and minimally invasive procedures) are all pointing up. The compensation still lands well above what most careers offer without a graduate degree.

What has changed is the bar. The reps winning offers in 2026 are more technically prepared and more strategic about how they land the job than the reps who broke in a decade ago.

A candidate hopped on a call with me last week and asked the question I've been getting nonstop this year. "Joe, is it still worth it? With AI, layoffs everywhere, and hiring feeling tight, is medical device sales still the career it used to be?"

Fair question, and an honest one. Here's what I'm seeing in real time from placing candidates at Stryker, Medtronic, Boston Scientific, Abbott, Johnson & Johnson MedTech, and dozens of other companies through RepPath.

The Demand Side Is Stronger Than Ever

Start with the fundamentals. Every major driver behind medical device sales is pointing up, not down. The U.S. population is aging, and baby boomers are moving into the highest-utilization years of their healthcare lives. Joint replacements, spine procedures, cardiac interventions, and cancer treatments are all trending up in volume.

The U.S. runs tens of millions of surgical procedures a year, and that number keeps climbing. Hospitals are pushing toward minimally invasive and robotic-assisted procedures because they cut recovery times and improve outcomes. Every one of those procedures involves a device, an implant, an energy platform, or a robotic system, and behind almost every one of those products is a sales rep who owns the account.

That demand does not disappear because the economy wobbles. Healthcare is one of the most recession-resistant industries in the country, and medical devices sit at the core of it. When candidates ask me if the industry is still worth pursuing, I point at the demographics first. The runway is long and clear.

The Technology Shift Is Real, and It Changes the Job

Here's where things have genuinely changed. The medical device rep of 2026 is not the same job it was in 2015. Robotics, imaging AI, and digital health platforms have moved from novelty to standard equipment in a growing number of ORs.

Da Vinci systems from Intuitive Surgical are installed in thousands of hospitals globally, running millions of procedures each year. Stryker's Mako has crossed more than a million total procedures in orthopedic cases across dozens of countries. The overall robotic surgery market has crossed the ten-billion-dollar mark and continues to grow at a strong clip.

For a sales rep, that means the job is more technical than it used to be. You're supporting robotic cases, walking surgeons through imaging integration, and answering deep clinical questions in real time. The reps who resist that shift tend to get outperformed by the reps who lean into it and build careers that pay well into six and seven figures over a decade.

Compensation in 2026 Still Punches Above Its Weight

Let's talk numbers, because that's usually the second question after "is it worth it." The financial upside in medical device sales is still one of the strongest in any career you can pursue without a medical or law degree.

Industry averages sit in the low-to-mid five figures for base salary, with total compensation including commissions typically in the mid-to-high six-figure range. Top performers in spine, structural heart, EP, and capital equipment routinely exceed that by a wide margin. Our RepPath clients see a median placed salary of $147,000 and average first-year earnings north of $125,000.

That's real money for a career that doesn't require years of postgraduate school. But it's not a free ride. The commission-heavy structure means your paycheck reflects your effort. The reps who show up, cover cases, defend their business, and grow accounts are the ones who take home the top-quartile numbers each year.

Where It's Gotten Harder (Be Honest With Yourself)

I'd be doing you a disservice if I pretended everything was easy in 2026. A few things have genuinely gotten more difficult:

  • Hiring bars are higher. Companies want reps who can support technical cases from day one. That means associate rep roles are more competitive than they were five years ago, and interview processes routinely stretch to four, five, or six rounds.
  • The job is physical and unpredictable. Territories often involve heavy driving, sometimes tens of thousands of miles a year, on-call weekends, and last-minute case coverage.

That's the trade in this industry. The upside is meaningful and the demands are meaningful, and anyone who tells you otherwise is selling you a version of the industry that doesn't exist.

The Kind of Rep Who Wins in This Market

The candidates I see winning offers at top companies in 2026 share a few traits. They study anatomy and procedures before they ever get in front of a hiring manager. They understand that a great personality is table stakes, not a differentiator.

They come prepared with a 30-60-90 day plan, a brag book, and clear answers on why they've chosen a specific specialty. That preparation is what carries them through the interview close when other candidates fumble the final ninety seconds.

They also treat networking like a job. The majority of medical device hires happen through referrals, not job boards, which is why the outreach mechanics we covered in the recruiter-response article matter so much. Reps who spend time building genuine relationships with reps, managers, and recruiters get in front of hiring decisions long before the general applicant pool ever sees the posting.

If that sounds like a lot of preparation, it is. That's why so many of our candidates at RepPath come to us before they've even started interviewing. We build the resume, the LinkedIn, the interview assets, and the outreach strategy together in 1-on-1 coaching, so they show up looking like a seasoned rep rather than a hopeful applicant. Certain backgrounds move through this process especially quickly, which is worth knowing before you assume you're at a disadvantage.

A Real RepPath Story

One of our recent placements, Isolde, came from an unrelated industry with no medical background and no formal sales experience. Inside the typical 9-10 week window our clients see from enrollment to signed offer, she had an offer as a Cardiovascular Sales Rep.

The difference between her outcome and the outcomes of candidates who struggle for a year came down to preparation and a clear plan, not luck or timing.

Frequently Asked Questions

Is medical device sales still hiring in 2026 despite tech layoffs?

Yes. Healthcare is one of the most recession-resistant sectors, and device companies are still actively hiring at all levels. Hiring bars are higher, but the roles are open.

Do I need a medical or science background to break in?

No. RepPath clients have come from nursing, physical therapy, athletic training, teaching, military, college athletics, pharma, and B2B sales in unrelated industries. What matters is coachability and how you present yourself in interviews.

Is AI going to replace medical device reps?

No. AI is changing what the job looks like, not eliminating it. Surgeons still need someone in the room who understands the equipment, the anatomy, and the procedure in real time. That's a human role for a long time to come.

How long does it take to land an offer with RepPath coaching?

Our clients average roughly 9-10 weeks from enrollment to a signed offer, with some cases landing closer to 90 days depending on background and market.

Ready to See If It's Worth It For You Specifically?

If you're on the fence about whether medical device sales is the right move in 2026, don't guess. Let's talk through your background, your goals, and your local market.

Book a free strategy call with me, or send me a note at joe@reppath.com. I'll bring the playbook I've used to help 500+ clients land offers in medical devices, capital equipment, pharma, and diagnostics, and we'll figure out together whether this career fits your life.

See you in the field.

Joe Licata
Founder, RepPath

Back to blog